Stephen Clarke is a medical oncologist at Royal North Shore Hospital in Sydney and Professor of Medicine at the University of Sydney. He is Director of Cancer Services in Northern Sydney LHD. Having completed his medical oncology training at RNSH, St Leonards, Stephen undertook a PhD at the Institute of Cancer Research/Royal Marsden Cancer Hospital, before returning to Australia in 1994. He worked at RPA and Concord Hospital until 2010 when he returned to RNSH. He has clinical and research interests in thoracic and GI cancers, including Neuroendocrine Cancers and mesothelioma as well as cancer pharmacology and cancer associated inflammation. Stephen’s research has achieved over $25 million in competitive grant funding that has led to over 300 publications, which have been cited over 14000 times. His work has been recognized by the awarding of an OAM in 2011, the Eric Susman prize of the RACP in 2012 and the MOGA Cancer Achievement Award in 2016. Stephen is the Oncology Advisor to the Department of Veteran’s Affairs and is a Member of the Repatriation Pharmaceutical Review Committee. He has been Head of the NSW State Committee of the RACP for 3 years.
Abstracts this author is presenting: